Literature DB >> 25802239

An ESMO-EORTC position paper on the EU clinical trials regulation and EMA's transparency policy: making European research more competitive again.

C Dittrich1, A Negrouk2, P G Casali3.   

Abstract

Mesh：

Year:  2015        PMID： 25802239     DOI： 10.1093/annonc/mdv154

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  4 in total

Review 1.  The value of anticancer drugs - a regulatory view.

Authors:  Francesco Pignatti; Ulla Wilking; Douwe Postmus; Nils Wilking; Julio Delgado; Jonas Bergh
Journal:  Nat Rev Clin Oncol       Date:  2021-12-06       Impact factor: 66.675

2.  Academically led clinical trials: challenges and opportunities.

Authors:  S Turajlic; J Larkin; C Swanton
Journal:  Ann Oncol       Date:  2015-08-03       Impact factor: 32.976

3.  Safeguarding the future of independent, academic clinical cancer research in Europe for the benefit of patients.

Authors:  Anastassia Negrouk; Denis Lacombe; Fatima Cardoso; Franck Morin; Eva Carrasco; Joan Maurel; Rudolf Maibach; Enrique Aranda; Richard Marais; Rolf A Stahel
Journal:  ESMO Open       Date:  2017-08-03

Review 4.  Challenges of international oncology trial collaboration-a call to action.

Authors:  Monica Tang; Heikki Joensuu; Robert J Simes; Timothy J Price; Sonia Yip; Wendy Hague; Katrin M Sjoquist; John Zalcberg
Journal:  Br J Cancer       Date:  2019-08-05       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.